Cancer immunomics: Using autoantibody signatures in the early detection of prostate cancer{star, open}

Urologic Oncology: Seminars and Original Investigations

Volumn 24, Issue 3, 2006, Pages 237-242

  Bradford, Timothy J ^a   Wang, Xiaoju ^a   Chinnaiyan, Arul M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Autoantibody signature; Biomarker; Prostate cancer

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; CANCER ANTIBODY; COMPLEMENTARY DNA; DNA FRAGMENT; IMMUNOGLOBULIN G; MESSENGER RNA; PEPTIDE; PROSTATE SPECIFIC ANTIGEN; TUMOR ANTIGEN;

AREA UNDER THE CURVE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER MORTALITY; CANCER TISSUE; DIAGNOSTIC ACCURACY; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; LUNG CANCER; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE;

ANTIGENS, NEOPLASM; AUTOANTIBODIES; AUTOANTIGENS; CASE-CONTROL STUDIES; EARLY DIAGNOSIS; HUMANS; MALE; PEPTIDE FRAGMENTS; PEPTIDE LIBRARY; PROSTATECTOMY; PROSTATIC NEOPLASMS; PROTEIN ARRAY ANALYSIS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 33646174413     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2005.11.033     Document Type: Review

References (19)

1. Crawford E.D. Epidemiology of prostate cancer. Urology 62 (2003) 3-12
2. Djavan B., Zlotta A., Kratzik C., et al. PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/mL. Urology 54 (1999) 517-522
3. Pannek J., and Partin A.W. The role of PSA and percent free PSA for staging and prognosis prediction in clinically localized prostate cancer. Semin Urol Oncol 16 (1998) 100-105
4. Sahin U., Tureci O., Schmitt H., et al. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 92 (1995) 11810-11813
5. Chen Y.T., Gure A.O., Tsang S., et al. Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc Natl Acad Sci USA 95 (1998) 6919-6923
6. Stockert E., Jager E., Chen Y.T., et al. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med 187 (1998) 1349-1354
7. Brichory F.M., Misek D.E., Yim A.M., et al. An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc Natl Acad Sci USA 98 (2001) 9824-9829
8. Minenkova O., Pucci A., Pavoni E., et al. Identification of tumor-associated antigens by screening phage-displayed human cDNA libraries with sera from tumor patients. Int J Cancer 106 (2003) 534-544
9. Zhong L., Peng X., Hidalgo G.E., et al. Antibodies to HSP70 and HSP90 in serum in non-small cell lung cancer patients. Cancer Detect Prev 27 (2003) 285-290
10. Pellat-Deceunynck C. Tumour-associated antigens in multiple myeloma. Br J Haematol 120 (2003) 3-9
11. Old L.J., and Chen Y.T. New paths in human cancer serology. J Exp Med 187 (1998) 1163-1167
12. Nilsson B.O., Carlsson L., Larsson A., et al. Autoantibodies to prostasomes as new markers for prostate cancer. Ups J Med Sci 106 (2001) 43-49
13. Mintz P.J., Kim J., Do K.A., et al. Fingerprinting the circulating repertoire of antibodies from cancer patients. Nat Biotechnol 21 (2003) 57-63
14. Soussi T. p53 Antibodies in the sera of patients with various types of cancer. A review. Cancer Res 60 (2000) 1777-1788
15. Sreekumar A., Laxman B., Rhodes D.R., et al. Humoral immune response to alpha-methylacyl-CoA racemase and prostate cancer. J Natl Cancer Inst 96 (2004) 834-843
16. Rubin M.A., Zhou M., Dhanasekaran S.M., et al. alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA 287 (2002) 1662-1670
17. Luo J., Zha S., Gage W.R., et al. alpha-Methylacyl-CoA racemase. A new molecular marker for prostate cancer. Cancer Res 62 (2002) 2220-2226
18. Jiang Z., Woda B.A., Rock K.L., et al. P504S. A new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol 25 (2001) 1397-1404
19. Wang X., Yu J., Sreekumar A., et al. Autoantibody signatures in prostate cancer. N Engl J Med 353 (2005) 1224-1235